AUG 15, 2022 8:00 AM PDT

Revolutionizing Healthcare Testing: 1health Unveils Next Generation Diagnostic Platform that Enables Precision Medicine at Scale

SPONSORED BY: 1health.io

SAN FRANCISCO, CA - July 11, 2022: 1health.io Inc. (“1health”), an industry-leading software company that empowers diagnostic laboratories to expand their testing in both the clinical and the direct-to-consumer markets rapidly and securely, partners with Apollo Health Group to bring Apollo’s specialized high performing NGS tests, such as hereditary cancer genetic screenings (CGx) and pharmacogenetics screenings (PGx) to the broader clinical market.

With 1health, Apollo Health Group is streamlining complex genetic testing workflows and eliminating error-prone paper-based processes. Now, using 1health’s online portal, physicians located anywhere across the United States can sign up and place orders digitally and securely and process test results quickly and safely. “With 1health’s technology, we are fundamentally changing the way people at risk of cancer and genetic disorders are able to get tested.

We have simplified a highly complex process and made it repeatable. Now cancer genetics and pharmacogenetics tests can be ordered in minutes online by any U.S. physician. The results are that people will get faster treatment and lives will be saved,” stated Apollo Health Group COO, Blaine Smith. “In addition, we were up and running in 30 days - which is an incredibly fast timeline for a project with this scope,” added Smith. “1health has made an incredibly complex process that includes multi-page patient questionnaires, sophisticated physician diagnosis reports, and laborious insurance documentation easy, fast, and secure,” states Mehdi Maghsoodnia, Chief Executive Officer of 1health. “What is even more powerful to understand is that now, through Apollo Health Group, these specialized tests can be ordered by physicians located anywhere across the U.S.

It enables Apollo to extend its market reach and help hundreds of thousands of people get access to these genetic tests,” added Maghsoodnia. Predictive genetic testing helps a physician understand how a person’s genetic composition may affect the body's response to medications and/or how inherited gene mutations might put a person at risk of getting cancer. The predictive genetic testing market is forecast to grow at 13.9% CAGR and reach USD 3.4 billion by 2027, according to The Market Research Future Report1.

About Apollo Health Group

Apollo Health Group is a laboratory-focused marketing and education platform that owns and operates a CLIA and COLO accredited high complexity molecular laboratory (Apollo Genetics) in Baton Rouge, Louisiana and a CLIA accredited high complexity lab in Draper, Utah (Apollo Diagnostics). The laboratories specialize in marketing and performing NGS tests such as hereditary cancer genetic screenings (CGx) and pharmacogenetics screenings (PGx), a variety of popular PCR tests such as Covid, Women’s Health, UTI, Wound Care, Respiratory Pathogen Panels, and a variety of blood tests, including IgE and IgG allergy tests. You can learn about Apollo Health Group at https://www.apollohealthgroup.net/

About 1health.io

1health is driving healthcare innovation by revolutionizing the way laboratories service healthcare providers and consumers. By providing a modern, secure, and easy-to-use software platform, 1health enables diagnostic testing results to be accurately delivered in minutes, not days or weeks, thereby reducing costs and expanding growth opportunities for laboratories. The result is stronger, more-trusted relationships between laboratories and their customers, better healthcare outcomes for consumers, and ultimately more lives saved. Learn more at https://1health.io.

Media Contact: Yasmin Hariri, Senior Marketing Manager at 1health.io

About the Sponsor
1health is driving healthcare innovation by revolutionizing the way laboratories service medical providers and consumers. By providing a modern, secure, and easy-to-use software platform, 1health enables lab testing results to be accurately delivered in minutes, not days or weeks, thereby reducing costs and expanding growth opportunities for laboratories. The result is stronger, more-trusted relationships between laboratories and their customers, better healthcare outcomes for consumers, and ultimately more lives saved. 1health is proud to help leading-edge laboratories like St. Jude Labs, Thomas Scientific, Lucira Health, Gene by Gene, Apollo Health Group, Premier Lab Solutions, and many others and provides testing services to hundreds of leading enterprise companies including Raley's, Starbucks, General Motors Cruise, and the U.S. Air Force. Learn more at: 1health.io.
You May Also Like
AUG 07, 2022
Health & Medicine
Antibiotic Resistance Genes of Mothers and Neonates in Low and Middle Income Countries
AUG 07, 2022
Antibiotic Resistance Genes of Mothers and Neonates in Low and Middle Income Countries
A team of international researchers examined the presence of antibiotic resistance genes (ARGs) in the gut microbiota of ...
SEP 07, 2022
Drug Discovery & Development
An Oral Insulin Pill is Getting Closer
SEP 07, 2022
An Oral Insulin Pill is Getting Closer
Diabetes is a chronic disease that requires constant monitoring. Patients have to check the level of sugar, or glucose i ...
SEP 19, 2022
Clinical & Molecular DX
Could Microplastics Disrupt Cellular Processes in Human Lungs and Livers?
SEP 19, 2022
Could Microplastics Disrupt Cellular Processes in Human Lungs and Livers?
Microplastics are tiny pieces of plastic that are shed from the larger pieces of plastic that we use every day. As plast ...
SEP 28, 2022
Health & Medicine
Drinking Tea Shown to Reduce Diabetes
SEP 28, 2022
Drinking Tea Shown to Reduce Diabetes
Researchers have discovered that drinking at least four cups of tea per day is associated with a 17% lower risk of type ...
SEP 30, 2022
Health & Medicine
Financial Incentive Influences Decision to Help for Less Empathic Individuals
SEP 30, 2022
Financial Incentive Influences Decision to Help for Less Empathic Individuals
A highly empathic person tends to help a person in need willingly, but what about those individuals with low empathy? A ...
OCT 04, 2022
Clinical & Molecular DX
The Human Brain Project is Changing What We Know About Lou Gehrig's Disease
OCT 04, 2022
The Human Brain Project is Changing What We Know About Lou Gehrig's Disease
Amyotrophic Lateral Sclerosis (ALS) is a progressive neuromuscular disease in which the motor nerve cells in the brain a ...
Loading Comments...